These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Expression of SATB1 and HER2 in gastric cancer and its clinical significance. Yuan CL; Li L; Zhou X; Liz H; Han L Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2256-64. PubMed ID: 27338049 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101). Matsusaka S; Nashimoto A; Nishikawa K; Miki A; Miwa H; Yamaguchi K; Yoshikawa T; Ochiai A; Morita S; Sano T; Kodera Y; Kakeji Y; Sakamoto J; Saji S; Yoshida K Gastric Cancer; 2016 Jul; 19(3):839-51. PubMed ID: 26265390 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of Grb2/HER2 signaling in Chinese gastric cancer: their relationship with clinicopathological parameters and prognostic significance. Yu GZ; Chen Y; Wang JJ J Cancer Res Clin Oncol; 2009 Oct; 135(10):1331-9. PubMed ID: 19337752 [TBL] [Abstract][Full Text] [Related]
5. HER2 in resected gastric cancer: Is there prognostic value? Fisher SB; Fisher KE; Squires MH; Patel SH; Kooby DA; El-Rayes BF; Cardona K; Russell MC; Staley CA; Farris AB; Maithel SK J Surg Oncol; 2014 Feb; 109(2):61-6. PubMed ID: 24122802 [TBL] [Abstract][Full Text] [Related]
6. Expression of SATB1 and HER2 in breast cancer and the correlations with clinicopathologic characteristics. Liu X; Zheng Y; Qiao C; Qv F; Wang J; Ding B; Sun Y; Wang Y Diagn Pathol; 2015 May; 10():50. PubMed ID: 25956130 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive analysis of HER2 expression and gene amplification in gastric cancers using immunohistochemistry and in situ hybridization: which scoring system should we use? Park YS; Hwang HS; Park HJ; Ryu MH; Chang HM; Yook JH; Kim BS; Jang SJ; Kang YK Hum Pathol; 2012 Mar; 43(3):413-22. PubMed ID: 21855114 [TBL] [Abstract][Full Text] [Related]
8. Early HER2 dysregulation in gastric and oesophageal carcinogenesis. Fassan M; Mastracci L; Grillo F; Zagonel V; Bruno S; Battaglia G; Pitto F; Nitti D; Celiento T; Zaninotto G; Fiocca R; Rugge M Histopathology; 2012 Nov; 61(5):769-76. PubMed ID: 22882541 [TBL] [Abstract][Full Text] [Related]
9. Intratumoral and intertumoral heterogeneity of HER2 immunohistochemical expression in gastric cancer. Zhang H; Wang Y; Wang Y; Wu D; Lin E; Xia Q Pathol Res Pract; 2020 Nov; 216(11):153229. PubMed ID: 33010699 [TBL] [Abstract][Full Text] [Related]
11. [Expression and significance of RhoA and NF-ΚB in human gastric carcinoma]. Su XJ; Tang ZF; Li Q; Li HL; Li LL; Liu M; Zhou YN Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):276-9. PubMed ID: 21575498 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathological features and endoscopic findings of HER2-positive gastric cancer. Oono Y; Kuwata T; Takashima K; Yoda Y; Ikematsu H; Shitara K; Kinoshita T; Yano T Surg Endosc; 2018 Sep; 32(9):3964-3971. PubMed ID: 29500656 [TBL] [Abstract][Full Text] [Related]
13. Comparison of intratumoral heterogeneity of HER2 expression between primary tumor and multiple organ metastases in gastric cancer: Clinicopathological study of three autopsy cases and one resected case. Saito T; Kondo C; Shitara K; Ito Y; Saito N; Ikehara Y; Yatabe Y; Yamamichi K; Tanaka H; Nakanishi H Pathol Int; 2015 Jun; 65(6):309-17. PubMed ID: 25828363 [TBL] [Abstract][Full Text] [Related]
14. SATB1 is an independent prognostic marker for gastric cancer in a Chinese population. Lu X; Cheng C; Zhu S; Yang Y; Zheng L; Wang G; Shu X; Wu K; Liu K; Tong Q Oncol Rep; 2010 Oct; 24(4):981-7. PubMed ID: 20811679 [TBL] [Abstract][Full Text] [Related]
15. Is her-2 status in the primary tumor correlated with matched lymph node metastases in patients with gastric cancer undergoing curative gastrectomy? Selcukbiricik F; Erdamar S; Buyukunal E; Serrdengecti S; Demirelli F Asian Pac J Cancer Prev; 2014; 15(24):10607-11. PubMed ID: 25605147 [TBL] [Abstract][Full Text] [Related]
16. Immuno-Histochemical Assessment of HER2NEU Expression in Gastric Adenocarcinoma in North Karnataka, India. Nadaf AS; Rani H; Dinesh US Asian Pac J Cancer Prev; 2018 May; 19(5):1381-1385. PubMed ID: 29802704 [TBL] [Abstract][Full Text] [Related]
17. Human epidermal growth-factor receptor 2 overexpression in gastric carcinoma in Thai patients. Sornmayura P; Rerkamnuaychoke B; Jinawath A; Euanorasetr C J Med Assoc Thai; 2012 Jan; 95(1):88-95. PubMed ID: 22379747 [TBL] [Abstract][Full Text] [Related]
18. The HER2 gene and HER2 protein status and chromosome 17 polysomy in gastric cancer cells in own material. Ciesielski M; Kruszewski WJ; Śmiałek U; Walczak J; Szajewski M; Szefel J; Wydra J; Kawecki K Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):113-7. PubMed ID: 25203430 [TBL] [Abstract][Full Text] [Related]
19. The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis. Fassan M; Pizzi M; Realdon S; Balistreri M; Guzzardo V; Zagonel V; Castoro C; Mastracci L; Farinati F; Nitti D; Zaninotto G; Rugge M Hum Pathol; 2013 Sep; 44(9):1804-10. PubMed ID: 23618359 [TBL] [Abstract][Full Text] [Related]
20. Expression of SATB1 and heparanase in gastric cancer and its relationship to clinicopathologic features. Cheng C; Lu X; Wang G; Zheng L; Shu X; Zhu S; Liu K; Wu K; Tong Q APMIS; 2010 Nov; 118(11):855-63. PubMed ID: 20955458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]